Qube Research & Technologies (QRT)’s Citius Pharmaceuticals CTXR Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio CTXR Stock Details CTXR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-2,884	Closed	-$36.1K	–	3514
2024 Q3	$36.1K	Sell	2,884 -6,355	-69%	-$107K	﹤0.01%	2906
2024 Q2	$135K	Buy	+9,239	New	+$166K	﹤0.01%	2534
2023 Q2	–	Sell	-4,004	Closed	-$117K	–	2488
2023 Q1	$117K	Sell	4,004 -819	-17%	-$23.6K	﹤0.01%	2090
2022 Q4	$95.3K	Buy	4,823 +716	+17%	+$19.5K	﹤0.01%	2017
2022 Q3	$124K	Sell	4,107 -744	-15%	-$20.4K	﹤0.01%	1910
2022 Q2	$112K	Buy	+4,851	New	+$133K	﹤0.01%	1900
2021 Q3	–	Sell	-3,425	Closed	-$298K	–	2305
2021 Q2	$298K	Buy	+3,425	New	+$206K	﹤0.01%	1585

Other funds holding CTXR

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

AWA

Arkadios Wealth Advisors Atlanta, Georgia $6.13B AUM 23.41% 1-Year Est. Return

Qube Research & Technologies (QRT)'s CTXR Position: Q4 2024 in Review

Qube Research & Technologies (QRT) sold out of Citius Pharmaceuticals (CTXR) in Q4 2024, closing a stake of 2,884 shares — an estimated $36.1K sold.

Qube Research & Technologies (QRT) first reported a position in CTXR in Q2 2021 and held it in 7 quarters. The position peaked at $298K in Q2 2021. 30 funds tracked by Wall St. Rank hold CTXR as of Q4 2024.

Qube Research & Technologies (QRT) reported no remaining Citius Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
Qube Research & Technologies (QRT) sold 2,884 Citius Pharmaceuticals shares in Q4 2024, an estimated $36.1K.
Qube Research & Technologies (QRT) first reported a position in Citius Pharmaceuticals in Q2 2021 and held it in 7 quarters.
Qube Research & Technologies (QRT)'s Citius Pharmaceuticals position peaked at $298K in Q2 2021.
30 funds tracked by Wall St. Rank held Citius Pharmaceuticals as of Q4 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2024, filed 14 Feb 2025.